drugset / Trial / NCT01314781
Therapy of the Overactive Bladder Syndrome
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of the present study is to investigate in patients with overactive bladder syndrome (OABS) whether a combination treatment of solifenacin with pelvic floor muscle training and whole body vibration training achieves a better treatment outcome than a treatment with solifenacin alone.
Timeline
- Start
- 2012-01
- Primary completion
- 2014-01
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Solifenacin | Small molecule | 5 mg | — |